Sorrento Therapeutics, Inc.

... ...
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 4.22%153.210.0%$2820.60m
BNGOBioNano Genomics, Inc. -0.91%12.470.0%$2656.95m
GILDGilead Sciences, Inc. -1.98%66.811.0%$665.99m
AMGNAmgen, Inc. -0.16%256.691.3%$583.75m
REGNRegeneron Pharmaceuticals, Inc. -0.33%546.392.7%$500.58m
ALXNAlexion Pharmaceuticals, Inc. 0.28%161.772.0%$480.33m
CRSPCRISPR Therapeutics AG -4.51%173.070.6%$456.60m
AXONAxovant Sciences Ltd 1.44%177.055.1%$441.72m
ILMNIllumina, Inc. -0.95%417.013.5%$438.56m
NVAXNovavax, Inc. -2.46%128.2392.9%$417.01m
VRTXVertex Pharmaceuticals, Inc. -0.76%239.471.9%$382.06m
SRPTSarepta Therapeutics, Inc. -2.52%93.6913.8%$357.67m
BIIBBiogen, Inc. -2.03%269.961.7%$327.47m
BNTXBioNTech SE -1.64%108.800.0%$309.81m
EXASEXACT Sciences Corp. -7.14%142.9419.6%$248.79m

Company Profile

Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. The company was founded by Henry H. Ji in 2006 and is headquartered in San Diego, CA.